1/ How can they charge $1000 per course for Ropren when the comparators they use in their trials can be bought freely for less than $30 of amazon.com. Before anybody says because Ropren works that much better, I have already pulled out the announcements and SLA has not provided enough information to make that determination.
A.....you have BIO-a and Ropren mixed up BIO-R's comparator is $16000, BIO-A is $30
2/ I don't get this stuff about IP and not being able to release results. NRT is developing Phenoxidial for cancer and it comes from plants and they release plenty of results. Even if they can't patent the substances, they can patent the methods of extraction and the uses, which would allow them to publish. This one really makes no sense to me.
A....patents still pending
3/ How do they know that demand is outstripping supply if they aren't selling Ropren yet? I have seen nothing to suggest that they have advance orders to support this claim. CMQ made these very same claims.
A.... Russian Govenment has pre ordered all they can supply at the moment.
Maybe you are tuggitback, Fartlow, or any number of other downrampers with a new NIC, or you should just go and DYOR
- Forums
- ASX - By Stock
- SLA
- a few questions
a few questions, page-22
Featured News
Add SLA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
David Keane, Co-Founder & CEO
David Keane
Co-Founder & CEO
Previous Video
Next Video
SPONSORED BY The Market Online